21 CFR 211

Difference Between 21 CFR Part 11 and EU GMP Annex 11
|

Difference Between 21 CFR Part 11 and EU GMP Annex 11

Navigating the complex waters of Life Sciences regulations? Two standards tower above the rest – 21 CFR Part 11 and EU GMP Annex 11. Here’s why they’re non-negotiable: Foundation of quality and integrity: Both safeguards ensure the highest standards of Quality, product integrity, and safety in the Life Sciences. Compliance isn’t just about checking legal…

Frequently Asked Questions and Answers on cGMP

Frequently Asked Questions and Answers on cGMP

Q1. Do the CGMP regulations require a firm to retain the equipment status identification labels with the batch record or other file? The CGMP regulations for finished pharmaceuticals require the retention of cleaning and use logs for non-dedicated equipment. But no similar requirement exists for retaining what are intended to be quick reference or temporary…

Inadequate Investigations: A Common Observation by the FDA
|

Inadequate Investigations: A Common Observation by the FDA

During cGMP inspections, one of the most commonly cited observations by the FDA is the inadequate investigation into deviations. Pharmaceutical companies must address this issue to maintain compliance and ensure patient safety. Here are some key points to keep in mind regarding deviation investigations in the pharmaceutical industry: Observation Highlight According to the FDA, many…

Vendor Qualification Under FDA and ICH Regulations
| |

Vendor Qualification Under FDA and ICH Regulations

All contract service organizations and vendors who supply the cGMP facility with critical supplies, reagents, and equipment must be qualified. This helps to ensure all products have been manufactured in a way that prevents the introduction of adventitious agents or toxic impurities and ensures final product safety, effectiveness, and consistency. However, setting up a supplier/vendor…